| Kory Dee Miskin, DPM | |
|
601 Sw Regional Airport Blvd, Bentonville, AR 72713-9256 | |
| (479) 553-2664 | |
| Not Available |
| Full Name | Kory Dee Miskin |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 11 Years |
| Location | 601 Sw Regional Airport Blvd, Bentonville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215376058 | NPI | - | NPPES |
| 217669717 | Medicaid | AR | |
| P01765552 | Other | RR MEDICARE | |
| 200681640A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 41000291A (Indiana) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 41000291A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Medical Center-springdale | Springdale, AR | Hospital |
| Siloam Springs Regional Hospital | Siloam springs, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Benton County Physician Services Llc | 3577503689 | 28 |
News Archive
Overweight women after menopause who eat a Paleolithic diet can maintain weight loss in the long term. The levels of risk factors of type 2 diabetes and cardiovascular diseases also decrease. This according to a study at Umeå University in Sweden.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.
In its commitment to provide diagnostic insights that enhance patient care and outcomes, Quest Diagnostics will automatically perform molecular testing on all patient specimens whose antibody screening results indicate hepatitis C virus infection, and remove standalone positive antibody screening as a test option.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
| Provider Name | Northwest Benton County Physician Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1871553073 PECOS PAC ID: 3577503689 Enrollment ID: O20050509000505 |
News Archive
Overweight women after menopause who eat a Paleolithic diet can maintain weight loss in the long term. The levels of risk factors of type 2 diabetes and cardiovascular diseases also decrease. This according to a study at Umeå University in Sweden.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.
In its commitment to provide diagnostic insights that enhance patient care and outcomes, Quest Diagnostics will automatically perform molecular testing on all patient specimens whose antibody screening results indicate hepatitis C virus infection, and remove standalone positive antibody screening as a test option.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
| Provider Name | Sgoh Acquisition Inc |
|---|---|
| Provider Type | Part B Supplier - Hospital Department(s) |
| Provider Identifiers | NPI Number: 1568643005 PECOS PAC ID: 5092616276 Enrollment ID: O20081016000559 |
News Archive
Overweight women after menopause who eat a Paleolithic diet can maintain weight loss in the long term. The levels of risk factors of type 2 diabetes and cardiovascular diseases also decrease. This according to a study at Umeå University in Sweden.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.
In its commitment to provide diagnostic insights that enhance patient care and outcomes, Quest Diagnostics will automatically perform molecular testing on all patient specimens whose antibody screening results indicate hepatitis C virus infection, and remove standalone positive antibody screening as a test option.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kory Dee Miskin, DPM 601 Sw Regional Airport Blvd, Bentonville, AR 72713-9256 Ph: (479) 553-2664 | Kory Dee Miskin, DPM 601 Sw Regional Airport Blvd, Bentonville, AR 72713-9256 Ph: (479) 553-2664 |
News Archive
Overweight women after menopause who eat a Paleolithic diet can maintain weight loss in the long term. The levels of risk factors of type 2 diabetes and cardiovascular diseases also decrease. This according to a study at Umeå University in Sweden.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.
In its commitment to provide diagnostic insights that enhance patient care and outcomes, Quest Diagnostics will automatically perform molecular testing on all patient specimens whose antibody screening results indicate hepatitis C virus infection, and remove standalone positive antibody screening as a test option.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
Mr. Stephen Samuel Pirotta, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 903 Se 22nd St, Suite 1, Bentonville, AR 72712 Phone: 479-271-5353 Fax: 479-254-0698 | |
Advanced Foot And Ankle Clinics Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 903 Se 22nd St, Ste 1, Bentonville, AR 72712 Phone: 479-271-5353 Fax: 479-254-0698 | |
Weldon Gene Murry Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 2900 Medical Center Pkwy Ste 140, Bentonville, AR 72712 Phone: 479-553-3100 |